News - Research, Legal


Current filters:


Popular Filters

EMA confirms AbbVie’s withdrawal of court cases on access to clinical-trial data


The European Medicines Agency confirms that US drugmaker AbbVie has withdrawn both its court cases brought…


EU clinical trials draft legislation approved by MEPs

EU clinical trials draft legislation approved by MEPs


Pharmaceutical companies and academic researchers will be obliged to upload the results of all their…


New legislation for regenerative medicine in Japan

New legislation for regenerative medicine in Japan


The Japanese legislature (Diet) has approved new legislation targeted at regenerative medicine therapies.…

Asia-PacificBiotechnologyCytori TherapeuticsLegalRegulationResearch

Report looks at impact of new law governing clinical trials in Switzerland

Report looks at impact of new law governing clinical trials in Switzerland


Clinical trials in Switzerland have been the subject of a new report carried out by the Swiss Federal…

Basilea PharmaceuticaEli LillyEuropeLegalNovartisPharmaceuticalResearchRoche

Court stops EMA from disclosing clinical trial documents from AbbVie and InterMune


The European Medicines Agency has been ordered by the General Court of the European Union not to provide…


Shire settles with Impax on Adderall XR authorized generic; initiates Ph III ABH001 study


Ireland-based drugmaker Shire (LSE: SHP) says it has settled all pending litigation with Impax Laboratories…

ABH001Adderall XRDermatologicalsGenericsImpax LaboratoriesLegalNeurologicalNorth AmericaPharmaceuticalResearchShire

US government takes steps to expose financial ties between drugmakers and doctors


After more than a year of prodding from the Senate Special Committee on Aging, the USA's federal government…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalResearch

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus


Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

Pfizer links with SFJ Pharma for dacomitinib trial; settles with Mylan


SFJ Pharmaceuticals Group, a global drug development group of companies which provides a unique co-development…

dacomitinibDetrol LAGastro-intestinalsGenericsLegalMylan LaboratoriesNorth AmericaOncologyPatentsPfizerPharmaceuticalResearchSFJ Pharmaceuticals

Mixed news on Lilly's Alzheimer's drug solanezumab; Alimta patent upheld


US drug major Eli Lilly (NYSE: LLY) revealed last Friday that the primary endpoints, both cognitive and…

AlimtaEli LillyLegalNeurologicalNorth AmericaOncologyPatentsPharmaceuticalResearchsolanezumabTeva Pharmaceutical Industries

Bipartisan Bill to strengthen testing of pediatric drugs launched in USA


US Representative Mike Rogers (Republican, Michigan) this week introduced bipartisan legislation with…

BiotechnologyLegalNorth AmericaPharmaceuticalRegulationResearch

New IP legislation will encourage medical research in Australia, says trade group


New legislation overhauling the Australian patent system will encourage medical research and bring Australia…


AstraZeneca in deal with Galapagos; view on Seroquel law suit


BioFocus and Argenta, service companies of Netherlands-based Galapagos (Euronext: GLPG), yesterday announced…

Argenta DiscoveryAstraZenecaBioFocusGalapagosLegalNeurologicalPharmaceuticalResearchRespiratory and PulmonarySeroquelSeroquel XR

US Court dismisses whistleblower case against Millennium Labs


US District Court Judge Joseph Tauro has ordered the complete dismissal of a whistleblower law suit against…

LegalMillennium LaboratoriesNorth AmericaPharmaceuticalResearch

Pharma industry could use a shot in the arm, says Fitch; FT views bribery settlements


2012 will be a critical year for the pharmaceutical industry, as drugmakers struggle with record patent…

FinancialLegalMarkets & MarketingPatentsPharmaceuticalResearch

Back to top